Healthcare
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
RedMed posted a stronger than expected first quarter, although various contingencies were reflected in the result and the subsequent outlook
Nov 03 2026
A US blood-supply crisis, incumbent technology being phased out and encouraging clinical validation are combining to strengthen the outlook for Vitrafy Life Sciences.
Oct 06 2026
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| 4DX | $2.35 | $7.55 | $1.40 | $4.20 | ||
| ACL | AUSTRALIAN CLINICAL LABS LIMITED | $3.25 | $3.32 | $1.83 | 16.4 | $2.95 |
| ALC | $0.11 | $0.14 | $0.08 | $0.15 | ||
| ARX | AROA BIOSURGERY LIMITED | $0.51 | $0.78 | $0.47 | 33.1 | $0.94 |
| AVH | AVITA MEDICAL INC | $4.95 | $5.15 | $1.00 | $5.65 | |
| AYA | $3.66 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| BB1 | $0.57 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| BIO | $0.39 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CAT | CATAPULT SPORTS LIMITED | $3.80 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CGS | $3.60 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| COH | COCHLEAR LIMITED | $152.40 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CSL | CSL LIMITED | $200.73 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CU6 | $1.66 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CUV | $7.42 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CYC | CYCLOPHARM LIMITED | $0.46 | $xx.xx | $xx.xx | xx.x | xx.xx |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $0.10 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBO | EBOS GROUP LIMITED | $17.69 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBR | EBR SYSTEMS INC | $0.17 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EGH | EUREKA GROUP HOLDINGS LIMITED | $0.62 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EIQ | $0.52 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| EMV | $1.48 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $39.38 | $xx.xx | $xx.xx | xx.x | xx.xx |
| HLS | HEALIUS LIMITED | $0.53 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $1.72 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IME | IMEXHS LIMITED | $0.35 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMM | $0.02 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| IMR | IMRICOR MEDICAL SYSTEMS INC | $1.28 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMU | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| INA | INGENIA COMMUNITIES GROUP | $5.28 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | $0.00 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| LDX | LUMOS DIAGNOSTICS HOLDINGS LIMITED | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| LIC | LIFESTYLE COMMUNITIES LIMITED | $4.37 | $xx.xx | $xx.xx | xx.x | xx.xx |
| M7T | MACH7 TECHNOLOGIES LIMITED | $0.26 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MAP | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MPL | MEDIBANK PRIVATE LIMITED | $5.32 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MSB | MESOBLAST LIMITED | $2.08 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVF | $0.75 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MVP | $0.44 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MX1 | MICRO-X LIMITED | $0.03 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MYX | $3.40 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| NAN | $2.85 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| NEU | NEUREN PHARMACEUTICALS LIMITED | $24.20 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NHF | NIB HOLDINGS LIMITED | $6.86 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NUZ | $0.06 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| OCA | OCEANIA HEALTHCARE LIMITED | $0.54 | $xx.xx | $xx.xx | xx.x | xx.xx |
| OCC | ORTHOCELL LIMITED | $0.60 | $xx.xx | $xx.xx | xx.x | xx.xx |
| ONE | ONEVIEW HEALTHCARE PLC | $0.14 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PAR | $0.25 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PGC | PARAGON CARE LIMITED | $0.16 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PHX | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PME | $205.89 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PNV | POLYNOVO LIMITED | $0.89 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PYC | PYC THERAPEUTICS LIMITED | $2.00 | $xx.xx | $xx.xx | xx.x | xx.xx |
| REG | $5.05 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| RHC | RAMSAY HEALTH CARE LIMITED | $55.94 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $34.13 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RYM | RYMAN HEALTHCARE LIMITED | $1.52 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SHL | SONIC HEALTHCARE LIMITED | $19.88 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SLD | $0.23 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| SNT | $0.02 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| SNZ | SUMMERSET GROUP HOLDINGS LIMITED | $5.02 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SOM | SOMNOMED LIMITED | $0.29 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TLX | TELIX PHARMACEUTICALS LIMITED | $13.80 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | $0.27 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
Telix Aims For A Strategic Isotope Supply Chain
Sep 24 2026
Telix Pharmaceutical’s proposed acquisition of a global isotope manufacturing supplier brings forth a strategically significant opportunity, although not without risks
Treasure Chest: Healthcare Upgrades
Sep 17 2026
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea involves Healthcare stocks
Undervalued Catapult Sports Plays A Bigger Game
Sep 16 2026
Proprietary data, an expanding product suite and cross-selling offers earnings upside for Catapult Sports
CSL’s FY26 Suggests The Downtrend Is Done
Aug 19 2026
CSL’s FY26 result and FY27 guidance suggest a recovery may be underway following a long run of downgrades
Rudi Interviewed: Bear Market Be Gone
Aug 13 2026
The FNArena Editor shares his views on investing, AI, Australian shares and about what to expect from the August results season
Strong Result, Can Telix Continue To Deliver?
Jul 22 2026
Telix has continued to outperform operationally in 2026, but future upside is increasingly dependent on pipeline execution, regulatory approvals and therapeutic progress.
Treasure Chest: Beware Aussie Healthcare
Jul 17 2026
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Australian healthcare stocks
Are Headwinds Building For ResMed In FY27?
Jul 14 2026
While one broker has turned more cautious on ResMed due to a one-off cost and risk of rising competition, analysts broadly welcome the MatrixCare sale as a strategic refocus backed by a sizeable shareholder return
A Technical Breakout For ResMed
Jul 07 2026
ResMed appears to have formed a technical bottom after breaking above key resistance, Fairmont Equities’ Michael Gable reports
Awaiting Catapult Sports’ Fundamental Re-Rating
Jun 15 2026
Following a stand-out FY26, analysts believe Catapult Sports’ execution and growth trajectory suggest a re-rating should follow
